These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
273 related articles for article (PubMed ID: 30092789)
1. TSSC3 promotes autophagy via inactivating the Src-mediated PI3K/Akt/mTOR pathway to suppress tumorigenesis and metastasis in osteosarcoma, and predicts a favorable prognosis. Zhao GS; Gao ZR; Zhang Q; Tang XF; Lv YF; Zhang ZS; Zhang Y; Tan QL; Peng DB; Jiang DM; Guo QN J Exp Clin Cancer Res; 2018 Aug; 37(1):188. PubMed ID: 30092789 [TBL] [Abstract][Full Text] [Related]
2. RanBP9/TSSC3 complex cooperates to suppress anoikis resistance and metastasis via inhibiting Src-mediated Akt signaling in osteosarcoma. Dai H; Lv YF; Yan GN; Meng G; Zhang X; Guo QN Cell Death Dis; 2016 Dec; 7(12):e2572. PubMed ID: 28032865 [TBL] [Abstract][Full Text] [Related]
3. RILP inhibits tumor progression in osteosarcoma via Grb10-mediated inhibition of the PI3K/AKT/mTOR pathway. Wei Z; Xia K; Zheng D; Gong C; Guo W Mol Med; 2023 Oct; 29(1):133. PubMed ID: 37789274 [TBL] [Abstract][Full Text] [Related]
4. MicroRNA‑22 mediates the cisplatin resistance of osteosarcoma cells by inhibiting autophagy via the PI3K/Akt/mTOR pathway. Meng CY; Zhao ZQ; Bai R; Zhao W; Wang YX; Xue HQ; Sun L; Sun C; Feng W; Guo SB Oncol Rep; 2020 Apr; 43(4):1169-1186. PubMed ID: 32323781 [TBL] [Abstract][Full Text] [Related]
5. AIM2 inhibits the proliferation, invasion and migration, and promotes the apoptosis of osteosarcoma cells by inactivating the PI3K/AKT/mTOR signaling pathway. Zheng J; Liu C; Shi J; Wen K; Wang X Mol Med Rep; 2022 Feb; 25(2):. PubMed ID: 34913077 [TBL] [Abstract][Full Text] [Related]
6. HER4 promotes the growth and metastasis of osteosarcoma via the PI3K/AKT pathway. Li X; Huang Q; Wang S; Huang Z; Yu F; Lin J Acta Biochim Biophys Sin (Shanghai); 2020 Apr; 52(4):345-362. PubMed ID: 32181480 [TBL] [Abstract][Full Text] [Related]
7. GPNMB silencing suppresses the proliferation and metastasis of osteosarcoma cells by blocking the PI3K/Akt/mTOR signaling pathway. Jin R; Jin YY; Tang YL; Yang HJ; Zhou XQ; Lei Z Oncol Rep; 2018 Jun; 39(6):3034-3040. PubMed ID: 29620278 [TBL] [Abstract][Full Text] [Related]
8. TSSC3 overexpression reduces stemness and induces apoptosis of osteosarcoma tumor-initiating cells. Huang Y; Dai H; Guo QN Apoptosis; 2012 Aug; 17(8):749-61. PubMed ID: 22610481 [TBL] [Abstract][Full Text] [Related]
9. Tumor-Suppressing STF cDNA 3 Overexpression Suppresses Renal Fibrosis by Alleviating Anoikis Resistance and Inhibiting the PI3K/Akt Pathway. Xiao F; Liu X; Chen Y; Dai H Kidney Blood Press Res; 2021; 46(5):588-600. PubMed ID: 34284400 [TBL] [Abstract][Full Text] [Related]
10. miR-155 Affects Osteosarcoma MG-63 Cell Autophagy Induced by Adriamycin Through Regulating PTEN-PI3K/AKT/mTOR Signaling Pathway. Wang L; Tang B; Han H; Mao D; Chen J; Zeng Y; Xiong M Cancer Biother Radiopharm; 2018 Feb; 33(1):32-38. PubMed ID: 29412697 [TBL] [Abstract][Full Text] [Related]
11. EEF1D overexpression promotes osteosarcoma cell proliferation by facilitating Akt-mTOR and Akt-bad signaling. Cheng DD; Li SJ; Zhu B; Zhou SM; Yang QC J Exp Clin Cancer Res; 2018 Mar; 37(1):50. PubMed ID: 29510727 [TBL] [Abstract][Full Text] [Related]
12. Eldecalcitol induces apoptosis and autophagy in human osteosarcoma MG-63 cells by accumulating ROS to suppress the PI3K/Akt/mTOR signaling pathway. Zhang C; Huang C; Yang P; Li C; Li M Cell Signal; 2021 Feb; 78():109841. PubMed ID: 33217539 [TBL] [Abstract][Full Text] [Related]
13. Effect of the Notch1-mediated PI3K-Akt-mTOR pathway in human osteosarcoma. Zhang K; Wu S; Wu H; Liu L; Zhou J Aging (Albany NY); 2021 Sep; 13(17):21090-21101. PubMed ID: 34495871 [TBL] [Abstract][Full Text] [Related]
14. Downregulation of long non-coding RNA DBH-AS1 inhibits osteosarcoma progression by PI3K-AKT signaling pathways and indicates good prognosis. Liu ZB; Wang JA; Lv RQ Eur Rev Med Pharmacol Sci; 2019 Feb; 23(4):1418-1427. PubMed ID: 30840262 [TBL] [Abstract][Full Text] [Related]
15. Licochalcone B Induced Apoptosis and Autophagy in Osteosarcoma Tumor Cells via the Inactivation of PI3K/AKT/mTOR Pathway. Huang Z; Jin G Biol Pharm Bull; 2022 Jun; 45(6):730-737. PubMed ID: 35431285 [TBL] [Abstract][Full Text] [Related]
16. MALAT1 promotes the proliferation and metastasis of osteosarcoma cells by activating the PI3K/Akt pathway. Dong Y; Liang G; Yuan B; Yang C; Gao R; Zhou X Tumour Biol; 2015 Mar; 36(3):1477-86. PubMed ID: 25431257 [TBL] [Abstract][Full Text] [Related]
17. SOCS5 inhibition induces autophagy to impair metastasis in hepatocellular carcinoma cells via the PI3K/Akt/mTOR pathway. Zhang M; Liu S; Chua MS; Li H; Luo D; Wang S; Zhang S; Han B; Sun C Cell Death Dis; 2019 Aug; 10(8):612. PubMed ID: 31406106 [TBL] [Abstract][Full Text] [Related]
18. P53 suppresses cell proliferation, metastasis, and angiogenesis of osteosarcoma through inhibition of the PI3K/AKT/mTOR pathway. Song R; Tian K; Wang W; Wang L Int J Surg; 2015 Aug; 20():80-7. PubMed ID: 25936826 [TBL] [Abstract][Full Text] [Related]
19. Knockdown of KRT17 decreases osteosarcoma cell proliferation and the Warburg effect via the AKT/mTOR/HIF1α pathway. Yan X; Yang C; Hu W; Chen T; Wang Q; Pan F; Qiu B; Tang B Oncol Rep; 2020 Jul; 44(1):103-114. PubMed ID: 32627037 [TBL] [Abstract][Full Text] [Related]
20. ZIC2 promotes viability and invasion of human osteosarcoma cells by suppressing SHIP2 expression and activating PI3K/AKT pathways. Huang S; Jin A J Cell Biochem; 2018 Feb; 119(2):2248-2257. PubMed ID: 28857346 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]